Find uplifting stories about heroes, innovations, and solutions
3702 results for "immunotherapy trials"
A silver Lab named Clarice beat cancer using an experimental treatment that's now paving the way for new immunotherapy options for children. The trial combined surgery, radiation, and immune-boosting injections to save her leg and her life.
A Pennsylvania mom facing her third tongue cancer surgery in six years joined a groundbreaking clinical trial at MD Anderson that saved her tongue and her quality of life. The trial uses immunotherapy injections to shrink precancerous lesions without surgery.
The Cancer Research Institute launched a patient resource hub connecting cancer patients with immunotherapy information and clinical trials. The platform features survivor stories and treatment guidance for those exploring cutting-edge cancer care options.
A groundbreaking clinical trial using immunotherapy before surgery instead of chemotherapy after has kept every single bowel cancer patient relapse-free for nearly three years. The results could transform treatment for one of the deadliest cancers affecting young adults.
Every single patient in a groundbreaking bowel cancer trial remains disease-free nearly three years after receiving immunotherapy before surgery. The treatment worked so well that more than half had no detectable cancer by the time they went in for their operations.
A Florida hospital is enrolling patients in a groundbreaking international study that could dramatically improve survival rates for advanced skin cancer. The trial tests whether immunotherapy before surgery can stop one of America's most common cancers from coming back.
Gordon Drygalski heard "I'm going to cure you" just weeks after a liver cancer diagnosis that friends said meant certain death. Today, thanks to an immunotherapy clinical trial at MD Anderson, he's living proof that early detection and innovative treatment can defeat one of medicine's toughest cancers.
A groundbreaking blood cancer trial in Melbourne achieved 96% remission rates by swapping harsh chemo drugs with gentler immunotherapy. Three young Victorians remain cancer-free three years later.
A groundbreaking immunotherapy trial has kept 32 bowel cancer patients cancer-free for nearly three years without chemotherapy. The treatment worked by teaching patients' immune systems to fight tumors before surgery, completely changing the standard treatment approach.
A groundbreaking Australian-led trial shows personalised mRNA therapy combined with immunotherapy cut melanoma recurrence by 49% in high-risk patients. It's the first late-stage success for personalised cancer vaccines.
A groundbreaking immunotherapy drug has shown stunning results in early trials, shrinking tumors in men with advanced prostate cancer who had run out of treatment options. Researchers believe this breakthrough could eventually lead to cures for a disease that affects 1.5 million men worldwide each year.
A 70-year-old Houston woman with advanced cervical cancer is now cancer-free after trying an experimental immunotherapy treatment. Her remarkable recovery offers new hope for patients facing similar diagnoses.
A groundbreaking therapy that teaches the body's immune system to recognize hidden cancer cells has shown encouraging results in early human trials. The treatment helped one in five patients with hard-to-treat cancers, offering new hope where other options had failed.
Every single patient in a groundbreaking bowel cancer trial remains cancer-free nearly three years after treatment, flipping the script on standard care. The experimental immunotherapy worked so well that more than half showed no cancer by surgery.
A breakthrough cancer treatment just beat the current standard of care in a major late-stage trial for biliary tract cancer patients. The drug, ivonescimab, helped patients live longer while experiencing fewer side effects than existing treatments.
A groundbreaking $4 million clinical trial in Canada is pairing gut bacteria capsules with immunotherapy to help lung cancer patients who aren't responding to standard treatments. If successful, the LUNA-2 trial could extend lives and reduce side effects for thousands of Canadians.
Clinical trials are getting faster thanks to artificial intelligence, but industry experts say strong relationships between researchers and trial sites remain the foundation of real progress. Better communication and collaboration could slash delays that happen before trials even begin.
Scientists have tested a surprising new approach to treating depression by targeting inflammation instead of brain chemicals alone. In a small UK trial, an arthritis drug helped 54% of patients with hard-to-treat depression achieve remission.
A groundbreaking clinical trial has just given Japanese patients with an aggressive form of lymphoma a powerful new treatment option. The SUNMO trial results convinced Japan's health ministry to approve the therapy as a new standard of care.
A groundbreaking trial is teaching children's immune systems to recognize and destroy aggressive cancers, offering fresh hope where traditional treatments fall short. The first patient has already enrolled in the study spanning the UK and US.
Showing 20 of 3702